Article Versions Notes

Coutinho MF, Santos JI, S. Mendonça L, Matos L, Prata MJ, S. Jurado A, Pedroso de Lima MC, Alves S. Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach. International Journal of Molecular Sciences. 2020; 21(16):5732. https://doi.org/10.3390/ijms21165732

Coutinho, Maria Francisca, Juliana Inês Santos, Liliana S. Mendonça, Liliana Matos, Maria João Prata, Amália S. Jurado, Maria C. Pedroso de Lima, and Sandra Alves. 2020. "Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach" International Journal of Molecular Sciences 21, no. 16: 5732. https://doi.org/10.3390/ijms21165732

Coutinho, M. F., Santos, J. I., S. Mendonça, L., Matos, L., Prata, M. J., S. Jurado, A., Pedroso de Lima, M. C., & Alves, S. (2020). Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach. International Journal of Molecular Sciences, 21(16), 5732. https://doi.org/10.3390/ijms21165732